Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

δ-Related Biomarkers Attenuate Multiple Alzheimer's Disease Conversion Risks and Offer Targets for Intervention.

The journals of gerontology. Series A, Biological sciences and medical sciences - 15 Oct 2020

Royall Donald R, Palmer Raymond F

Abstract excerpt

BACKGROUND: We tested certain serum proteins' ability to mediate the effects of demographic variables on prospective 5-year conversion to clinical "Alzheimer's disease" from non-demented states (i.e. normal control and mild cognitive impairment). The proteins were rationally selected from previously published mediators of those same variables' (plural posessive) association with the latent variable "δ," a novel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Blood Proteins

Share to Disease Progression

Share to Phenotype

Share to Risk Factors

Source

Identifiers

PMID: 31665233
DOI: 10.1093/gerona/glz253

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

δ-Related Biomarkers Attenuate Multiple Alzheimer's Disease Conversion Risks and Offer Targets for Intervention.PMID 31665233Read ↗

The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.Semantic proximity Read ↗

Formulating Treatment to Cure Alzheimer’s DementiaSemantic proximity Read ↗

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.Semantic proximity Read ↗

The δ latent dementia phenotype in the uniform data set: Cross-validation and extension.Semantic proximity Read ↗

The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.Semantic proximity Read ↗

Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study.Semantic proximity Read ↗

Nonlinear biomarker interactions in conversion from Mild Cognitive Impairment to Alzheimer’s diseaseSemantic proximity Read ↗

Statin use moderates APOE's and CRP's associations with dementia and is associated with lesser dementia severity in ε4 carriers.Semantic proximity Read ↗

Seven routine blood markers predict five-year mortality in older Indians: a risk score from the LASI-DAD cohortSemantic proximity Read ↗

Lost in translation: epidemiology, risk, and Alzheimer disease.Semantic proximity Read ↗

Vitamin D Binding Protein as a Serum Biomarker of Alzheimer's DiseaseSemantic proximity Read ↗

Assessing adipokines as potential biomarkers of dementia, Alzheimer’s disease, and mild cognitive impairment: a systematic review and meta-analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.